1. Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System

   • Patrícia Schonhofen
   • Ivi Juliana Bristot
   • Fábio Klamt

   Current Opinion 14 August 2018 Pages: 697 - 712

   

2. Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents

   • Richard E. Frye

   Review Article Open access 14 August 2018 Pages: 713 - 734

3. Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache Disorders

   • Michael J. Marmura
   • Aliza S. Kumpinsky

   Review Article 02 August 2018 Pages: 735 - 746

4. Drug Repurposing in Parkinson’s Disease

   • Dilan Athauda
   • Thomas Foltynie

   Review Article 31 July 2018 Pages: 747 - 761

5. The Effect of Glatiramer Acetate on Retinal Nerve Fiber Layer Thickness in Patients with Relapsing–Remitting Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study

   • Robert Zivadinov
   • Eleonora Tavazzi
   • Bianca Weinstock-Guttman

   Original Research Article 16 May 2018 Pages: 763 - 770

6. Use of Emergency Medication in Adult Patients with Epilepsy: A Multicentre Cohort Study from Germany

   • Jeannette Kadel
   • Sebastian Bauer
   • Adam Strzelczyk

   Original Research Article 17 July 2018 Pages: 771 - 781

   

7. Correction to: Treatment Strategies for Dravet Syndrome

   • Kelly G. Knupp
   • Elaine C. Wirrell

   Correction 20 July 2018 Pages: 783 - 783

8. Cladribine Tablets: A Review in Relapsing MS

   • Emma D. Deeks

   Adis Drug Evaluation Open access 14 August 2018 Pages: 785 - 796

9. Amantadine Extended-Release (GOCOVRI^™): A Review in Levodopa-Induced Dyskinesia in Parkinson’s Disease

   • Julia Paik
   • Susan J. Keam

   Adis Drug Evaluation 07 August 2018 Pages: 797 - 806